UK political uncertainty 'damaging' for pharma, says ABPI

With concern among much of UK life sciences sector at the hard-Brexit rhetoric of Theresa May but Labour Leader Jeremy Corbyn having risked the wrath of pharma by calling for greater nationalization of medical research, it is hard to know what industry executives must be making of the latest surprise result in a UK political vote.

Seeking a strong hand in the upcoming negotiations on the UK’s exit from the European Union, in April Mrs May called a general election, with predictions at the time suggesting that she might increase the Conservatives’ majority in the House of Commons.

"In all scenarios, we will need continued co-operation with Europe on all aspects of medicines regulation"